Monitoring the safety of over the counter drugs - We need a better way than spontaneous reports

被引：21

作者：

Clark, D ^{[1
]}

Layton, D

Shakir, SAW

机构：

[1] Univ Otago, Dept Pharmacol, Dunedin, New Zealand

[2] Drug Safety Res Unit, Southampton SO31 1AA, Hants, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2001年 / 323卷 / 7315期

关键词：

D O I：

10.1136/bmj.323.7315.706

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：706 / 707

页数：2

共 14 条

[1]

[Anonymous], CURR PROBL PHARM

[2]

Bradley C, 1996, BRIT MED J, V312, P835

[3]

Gauld NJ, 2000, PHARMACOEPIDEM DR S, V9, P207, DOI 10.1002/1099-1557(200005/06)9:3<207::AID-PDS483>3.0.CO

[4]

2-S

[5]

INMAN WHW, 1980, MONITORING DRUG SAFE, P36

[6]

JICK H, 1984, LANCET, V1, P1017

[7] Phenylpropanolamine and the risk of hemorrhagic stroke. [J].

Kernan, WN ;

Viscoli, CM ;

Brass, LM ;

Broderick, JP ;

Brott, T ;

Feldmann, E ;

Morgenstern, LB ;

Wilterdink, JL ;

Horwitz, RI .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1826-1832

[8] ADVERSE DRUG EFFECTS ATTRIBUTED TO PHENYLPROPANOLAMINE - A REVIEW OF 142 CASE-REPORTS [J].

LAKE, CR ;

GALLANT, S ;

MASSON, E ;

MILLER, P .

AMERICAN JOURNAL OF MEDICINE, 1990, 89 (02) :195-208

[9]

Mann RD, 1997, PHARMACOEPIDEM DR S, V6, pS5, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S5::AID-PDS272>3.3.CO

[10]

2-6

← 1 2 →